BCL2 and neoplasm: Especially the ITGAV/ITGB3 heterodimer has been connected with tumor neoangiogenesis via high levels of bFGF and tumor-necrosis factor α (TNFA) whereas the ITGAV/ITGB1 receptor is implicated in tumor cell proliferation via BCL2 and p53 activity22.